Webinar | July 10, 2018

Protein Therapeutics By Immunoaffinity LC-MS: Latest Trends And Recommendations

Source: Q2 Solutions

Significant developments have impacted the application of immunoaffinity liquid chromatography-mass spectrometry (LC-MS) to regulated biotherapeutics. This presentation focuses on the latest LC-MS technologies and techniques that are impacting the development of protein-based drugs. Approaches taken are in line with industry trends and regulatory expectations established around bioanalysis.